Glycogen Metabolism

2. Glycogen Metabolism

Storage, Synthesis, and Mobilization of the Branched Glucose Polymer

2. Glycogen Metabolism

Glycogen is a massive, highly branched homopolymer of D-glucose residues that serves as the primary mobilized storage form of carbohydrate in animals and microorganisms.

2.1 Structural Architecture and Physiological Roles

Primary Chains: Constructed of glucose monomers joined by α-1,4-glycosidic bonds.
Branch Points: Arise via α-1,6-glycosidic bonds occurring approximately every tenth glucose residue along the main chain. This highly branched structure increases the solubility of the polymer and creates a vast number of non-reducing terminal ends, allowing for rapid, simultaneous degradation or synthesis by enzymatic machinery.

Figure: Branched architecture of glycogen. Glucose residues (G) are linked in linear chains by α-1,4-glycosidic bonds. At the branch-point residue, an α-1,6-glycosidic bond launches a second chain into its own branch, so the two chains terminate in separate non-reducing ends — multiplying the number of sites available for simultaneous enzymatic attack. The single reducing end remains covalently anchored to the glycogenin protein core.

2.1.1 Physiological Roles of Adipose and Hepatic Glycogen

Glycogen is stored as dense, cytosolic granules in two primary tissues:

Skeletal Muscle: Stores the largest total quantity of glycogen in the body due to its massive tissue mass. Muscle tissue utilizes these glycogen stores exclusively to generate G6P for its own glycolytic needs during contraction. It lacks glucose-6-phosphatase and cannot release free glucose into blood circulation.
The Liver: Maintains glycogen at a much higher concentration per gram of tissue than muscle. The liver mobilizes its glycogen granules to release free D-glucose into the bloodstream, maintaining blood glucose levels for systemic tissues during periods of fasting or exercise.

2.2 Glycogenesis: The Synthesis of Glycogen

The synthesis of glycogen from glucose 6-phosphate proceeds through three highly regulated sequential steps:

Step 1: Isomerisation of Glucose 6-Phosphate to Glucose 1-Phosphate

Glucose 6-phosphate (G6P) is reversibly isomerized to glucose 1-phosphate (G1P) by the enzyme phosphoglucomutase:

Glucose 6-phosphate Phosphoglucomutase⇌ Glucose 1-phosphate

Step 2: Activation to a Sugar Nucleotide (UDP-Glucose)

To drive the polymerization of glucose residues forward, G1P must be activated to a high-energy sugar nucleotide intermediate. This reaction is catalyzed by UDP-glucose pyrophosphorylase:

Glucose 1-phosphate + UTP UDP-glucose Pyrophosphorylase⇌ UDP-glucose + PP_i

Mechanism: The oxygen atom on the phosphate of G1P attacks the alpha-phosphate of UTP, releasing pyrophosphate (PP_i).
Thermodynamic Driving Force: Although this activation reaction is highly reversible, intracellular inorganic pyrophosphatase rapidly and irreversibly hydrolyzes the released PP_i into two molecules of inorganic orthophosphate (P_i):
PP_i + H₂O → 2 P_i (ΔG^0′ = −19 kJ/mol)
This highly exergonic hydrolysis pulls the overall activation reaction forward, making UDP-glucose synthesis irreversible in vivo.

Figure: Sugar-nucleotide activation. Glucose 1-phosphate reacts with UTP to form UDP-glucose and pyrophosphate; rapid hydrolysis of the pyrophosphate to two orthophosphates makes the overall activation step thermodynamically irreversible in the cell.

Step 3: Chain Elongation by Glycogen Synthase

Glycogen synthase transfers the glucosyl residue from UDP-glucose to the C-4 hydroxyl group of a non-reducing terminal end of an existing glycogen chain, forming an α-1,4-glycosidic bond and releasing free UDP:

UDP-glucose + Glycogen (N residues) Glycogen Synthase→ UDP + Glycogen (N+1 residues)

The Primer Requirement and Glycogenin: Glycogen synthase cannot synthesize glycogen de novo; it can only append glucosyl residues to an existing glucan chain containing more than four residues. To initiate glycogen synthesis, a protein primer called glycogenin is required.

Glycogenin is a homodimeric protein that functions as a specialized glycosyltransferase.
Each monomer of glycogenin catalyzes the addition of a glucose unit from UDP-glucose to its partner monomer.
The first glucosyl residue is covalently attached to the hydroxyl group of a specific tyrosine residue (Tyr-194) on the glycogenin protein.
Glycogenin continues to append glucose residues to form an oligosaccharide primer chain of approximately 8 residues, which then serves as a substrate for glycogen synthase.

2.2.1 Formation of Branch Chains

Glycogen synthase is restricted to forming linear α-1,4-glycosidic bonds. Branching is performed by a separate, specialized enzyme called the glycogen-branching enzyme (also known as amylo-1,4 → 1,6 transglycosylase):

The branching enzyme cleaves a 6- or 7-unit segment from the non-reducing terminal end of an α-1,4 main chain that is at least 11 residues long.
It transfers this oligomeric segment to the C-6 hydroxyl group of a glucose residue located further down on the same or another glycogen chain, creating an α-1,6-glycosidic branch point.
To prevent steric hindrance, the new branch point must be established at least four residues away from any pre-existing branch point. Branching increases the solubility of glycogen and creates multiple non-reducing ends for rapid degradation.

2.3 Glycogenolysis: The Degradation of Glycogen

The mobilization of glucose from stored glycogen requires the coordinated action of two distinct cytosolic enzymes to produce glucose 1-phosphate and free glucose:

Step 1: Phosphorolysis by Glycogen Phosphorylase

Glycogen phosphorylase is the key regulatory enzyme of glycogenolysis. It cleaves the terminal α-1,4-glycosidic bonds from the non-reducing ends of glycogen by adding inorganic orthophosphate (P_i), releasing α-D-glucose 1-phosphate (G1P):

Glycogen (N residues) + P_i Glycogen Phosphorylase→ Glycogen (N−1 residues) + Glucose 1-phosphate

Structure and the PLP Cofactor: Glycogen phosphorylase is a dimer composed of two identical subunits (each containing 842 amino acid residues). The enzyme requires pyridoxal phosphate (PLP), a vitamin B₆ derivative, as an essential cofactor. PLP is covalently linked to a specific lysine residue (Lys-680) via a Schiff base. Unlike its role in transamination reactions, the phosphate group of PLP acts as a general acid-base catalyst to facilitate the nucleophilic attack of inorganic phosphate on the glycosidic bond.

The Debranching Limit: Glycogen phosphorylase acts processively down the glycogen chain, cleaving α-1,4 bonds until it reaches a point four glucose residues away from an α-1,6 branch point. At this point, steric hindrance prevents further phosphorylase activity, and this trimmed structure is called a limit dextrin.

Step 2: Debranching by the Glycogen Debranching Enzyme

To degrade glycogen past the limit dextrin stage, a bifunctional enzyme called the glycogen debranching enzyme performs two sequential activities:

Figure: Debranching cascade. The bifunctional debranching enzyme first transfers three of the four remaining branch residues onto the main chain (extending it for phosphorylase), then hydrolyzes the single residue still attached at the α-1,6 branch point, releasing free glucose.

Transferase Activity (oligo-α1,4 → α1,4-glucantransferase): The enzyme removes the terminal three glucose residues of the remaining four-residue branch and transfers this trisaccharide moiety intact to the non-reducing terminal end of another linear chain, extending the substrate for glycogen phosphorylase.
α(1→6) Glucosidase Activity: The remaining single glucose residue attached directly to the main chain via the α-1,6-glycosidic linkage is hydrolytically cleaved by the same enzyme, releasing one molecule of free, unphosphorylated glucose.

Thus, the complete degradation of glycogen yields approximately 92% glucose 1-phosphate (which is converted to G6P for glycolysis or gluconeogenesis) and 8% free glucose (derived from the hydrolyzed branch points).

3. Coordinate Hormonal Regulation

How Insulin, Glucagon, and Epinephrine Balance Carbohydrate Metabolism

3. Coordinate Hormonal Regulation of Carbohydrate Metabolism

To prevent wasteful, simultaneous operation of synthesis and degradation pathways (futile cycling), glycogenesis, glycogenolysis, and gluconeogenesis are coordinately regulated by the hormones insulin, glucagon, and epinephrine.

3.1 Hormonal Signal Transduction Pathways

Glucagon: A 29-amino-acid polypeptide hormone synthesized and secreted by the α-cells of the pancreatic islets. It binds to G-protein coupled receptors (GPCR) primarily in the liver to stimulate glycogenolysis and gluconeogenesis, maintaining blood glucose during fasting.
Epinephrine (Adrenaline): A tyrosine-derived catecholamine hormone synthesized and secreted by the adrenal medulla during stress or exercise (the "fight-or-flight" response). It binds to GPCRs in both the liver and skeletal muscle, triggering rapid glycogen degradation to produce energy.

The cAMP Second Messenger Cascade

Both glucagon and epinephrine bind to their respective transmembrane GPCRs, activating a highly amplified intracellular phosphorylation cascade:

Figure: The cAMP second-messenger cascade. Hormone binding activates a G-protein, which stimulates adenylate cyclase to raise cAMP and activate PKA. PKA output splits into two coordinated arms: it activates phosphorylase kinase to switch glycogenolysis on, while simultaneously helping inactivate glycogen synthase to switch glycogenesis off.

G-Protein Activation: Receptor binding causes the exchange of GDP for GTP on the G-protein α-subunit, activating the heterotrimeric G-protein.
Adenylate Cyclase: The active G_sα subunit stimulates adenylate cyclase to convert ATP into cyclic AMP (cAMP).
Activation of PKA: Elevated cAMP binds to the regulatory subunits of protein kinase A (PKA), releasing and activating its catalytic subunits.
Activation of Phosphorylase Kinase: Active PKA phosphorylates phosphorylase kinase, converting it from its inactive to its active form.
Activation of Glycogen Phosphorylase: Active phosphorylase kinase phosphorylates glycogen phosphorylase, converting it from its inactive b form to its highly active a form by targeting a single serine residue on each subunit.
Concurrent Inactivation of Glycogen Synthase: Concurrently, PKA and glycogen synthase kinase 3 (GSK3) phosphorylate glycogen synthase, converting it from its active a form (dephosphorylated) to its inactive b form (phosphorylated).

This dual-targeted cascade ensures that glycogen degradation is immediately activated while glycogen synthesis is completely shut down.

3.2 The Role of Insulin in Carbohydrate Homeostasis

Insulin is a 51-amino-acid polypeptide hormone produced and secreted by the β-cells of the islets of Langerhans in the pancreas in response to high blood glucose levels.

Structure: Composed of two polypeptide chains (A and B) joined together by two interchain disulfide bridges, with a third intrachain disulfide link in chain A.

Action of Insulin

Insulin acts as a direct physiological antagonist to glucagon and epinephrine:

Promotes Glucose Uptake: In skeletal muscle and adipose tissues, insulin binding to its receptor triggers the translocation of glucose transporter 4 (GLUT4) vesicles to the plasma membrane, facilitating glucose transport into cells.
Activates Glycogen Synthesis: Insulin activates protein phosphatase 1 (PP1). PP1 removes the phosphate groups from glycogen phosphorylase (inactivating it) and glycogen synthase (converting it to its active a form), driving glycogenesis.
Inhibits Gluconeogenesis: Insulin signaling reduces the transcription of key gluconeogenic enzymes, such as PEPCK and glucose-6-phosphatase, halting de novo glucose production in hepatocytes.

3.3 Comparative Summary: Insulin vs. Glucagon & Epinephrine

The opposing physiological effects of these hormones on carbohydrate metabolism are summarized below:

Metabolic Pathway	Effect of Insulin	Effect of Glucagon & Epinephrine	Key Regulatory Enzyme(s)
Glycogenesis (Synthesis)	Stimulates	Inhibits	Glycogen Synthase (a active, b inactive)
Glycogenolysis (Degradation)	Inhibits	Stimulates	Glycogen Phosphorylase (a active, b inactive)
Gluconeogenesis (De Novo)	Inhibits	Stimulates	FBPase-1, PEPCK, Pyruvate Carboxylase
Glycolysis (Breakdown)	Stimulates	Inhibits	PFK-1, Pyruvate Kinase

4. Glycogen Storage Diseases

Hereditary Enzyme Deficiencies in Glycogen Metabolism (GSD)

4. Glycogen Storage Diseases (GSD)

Hereditary genetic deficiencies in any of the primary enzymes involved in glycogen synthesis, degradation, or compartmentalisation result in severe clinical pathologies. These are classified as Glycogen Storage Diseases (GSD):

Disease Name	Defective Enzyme	Primary Pathological Site(s)	Clinical Pathology and Symptoms
Von Gierke's disease (Type I)	Glucose-6-phosphatase	Liver and kidney	Severe fasting hypoglycemia, hepatomegaly, lactic acidosis, hyperlipidemia, and gout due to the inability of the liver to release free glucose into circulation.
Pompe's disease (Type II)	Lysosomal α1→4 and α1→6 glucosidase (acid maltase)	Generalized (all organs, especially heart/skeletal muscle)	Accumulation of glycogen within lysosomes, leading to severe cardiorespiratory failure and early death.
Hers' disease (Type VI)	Liver glycogen phosphorylase	Liver	Mild fasting hypoglycemia, hepatomegaly; clinical symptoms are generally benign compared to Von Gierke's.
Tarui's disease (Type VII)	Muscle and erythrocyte phosphofructokinase 1 (PFK-1)	Muscle and erythrocytes	Muscle cramping and pain during exercise, exercise-induced hemolysis, and mild anemia.
McArdle's disease (Type V)	Muscle glycogen phosphorylase	Skeletal muscle	Muscle cramping, pain, and fatigue during strenuous exercise; characterized by a flat venous lactate curve during ischemic exercise.
Andersen's disease (Type IV)	Amylo (1,4→1,6) transglycosylase (branching enzyme)	Liver and muscle	Synthesis of abnormal, poorly branched glycogen (resembling amylose) that elicits an immune response, leading to progressive liver cirrhosis and early death.

In this lesson

Carbohydrate Metabolism: Gluconeogenesis and Glycogen

LessonStep 40 of 61

Next quizCarbohydrate Metabolism: Gluconeogenesis and Glycogen